The search for a domestic supply of the radioisotope technetium-99m (tech-99) may have to begin anew as General Electric has temporarily put the brakes on a project at an Illinois nuclear power plant that would have produced molybdenum-99 (Mo-99), which decays into tech-99.

Positron has acquired all of the assets and business operations and retained all employees of Manhattan Isotope Technology (MIT). In exchange, MIT will receive cash advances, assumption of certain indebtedness and earn-out consideration of $3.5 million, based on 20 percent of the net income from sales relating to radioisotope and radiopharmaceutical operations of MIT.

Following a two-day public hearing, the Canadian Nuclear Safety Commission announced its decision Oct. 27 to renew the Atomic Energy of Canada Limited's (AECL) Chalk River Laboratories operating license for a period of five years. The license will be valid from Nov. 1 until Oct. 31, 2016.

Advanced Medical Isotope Corporation (AMIC), a developer and distributor of medical isotopes, has engaged the Moscow-based Global TechInnovations for assistance in acquiring a Russian company that specializes in the production and sales of radioactive isotopes used for medical diagnostic and therapeutic uses.

The Federal Trade Commission (FTC) found that Cardinal Health’s purchase of nuclear pharmacies from Biotech was anticompetitive and will require the company to reconstitute and sell facilities located in Las Vegas, Albuquerque, N.M. and El Paso, Texas. The commission claimed Cardinal’s purchases reduced competition for low-energy radiopharmaceuticals in the three cities.

NorthStar Medical Radioisotopes has located a new 82,000 square-foot, $194 million production facility in Beloit, Wis., where the company hopes to create 150 jobs by 2016. The new facility will utilize linear accelerators to produce radioisotopes used for medical imaging.

The University of Oklahoma in Norman, Okla., has completed installation of ABT Molecular Imaging's Biomarker Generator at the College of Pharmacy, enabling researchers at the university to have local access to PET radioisotopes.

Positron, a nuclear cardiology company, has executed a memorandum of understanding with the City of Noblesville, Ind., to relocate its corporate headquarters, research & development and product manufacturing facilities to Noblesville.